SARS-CoV-2 Lambda and Gamma variants competition in Peru, a country with high seroprevalence
Saved in:
Main Authors: | Natalia Vargas-Herrera (Author), Roger V Araujo-Castillo (Author), Orson Mestanza (Author), Marco Galarza (Author), Nancy Rojas-Serrano (Author), Lely Solari-Zerpa (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Interferon alpha, gamma, and lambda 2: are they possible culprits in the association between psoriasis and hepatitis C virus?
by: Randa Youssef, et al.
Published: (2019) -
Genetic variants of interferon lambda-related genes and chronic kidney disease susceptibility in the Korean population
by: Jin Ho Kwak, et al.
Published: (2022) -
Lambda Interferons: New Cytokines with Old Functions
by: Ole J. Hamming, et al.
Published: (2010) -
The majestic echolalia of variants: the impasse of scientists in trying to recognize one from another. Proposal of TCM to treat skin disorders in epsilon and lambda variants (COVID-19)
by: Lorenzo Martini, et al.
Published: (2021) -
Reaching the theoretical herd immunity threshold in Iquitos, Peru: are seroprevalence data enough?
by: Stella M Chenet, et al.
Published: (2021)